DJIA 17,826.30 -279.47 -1.54%
NASDAQ 4,931.82 -75.98 -1.52%
S&P 500 2,081.18 -23.81 -1.13%
market minute promo


company name or ticker

Biotech of the Week: Opko Health Inc.

Opko Health competes with Laboratory Corporation of America and Quest Diagnostics on the diagnostics side and is partnered with Tesaro on the therapeutics side.

Relative Strength Alert For Tesaro

Should You Buy Tesaro After Its Earnings Miss?

Tesaro just missed earnings estimates by $0.37 per share for its first quarter. Is this stock a bad news buy?

TESARO's (TSRO) CEO Lonnie Moulder on Q1 2014 Earnings - Call Transcript

TESARO's CEO Discusses Q1 2014 Results - Earnings Call Transcript

Is Biotech in a Bubble? The Bear Case Explained

Biotech IPOs provide some powerful indications...

Why 2014 May Be a Big Year for Opko Health, Inc.

Opko's (OPK) has a number of catalysts this year that could have a big impact on its biggest investor, Philip Frost; including a Tesaro's (TSRO) potential FDA filing for Rolapitant.

Myriad Genetics Inks HRD Alliance with Tesaro - Analyst Blog

3 Stocks to Get on Your Watchlist

SodaStream, Cisco, and Opko Health are this week's must-watch stocks.

Five Prime, Bristol-Myers Squibb Cut $350M Immuno-Oncology Deal

Five Prime, Bristol-Myers Squibb cut $350M immuno-oncology deal.
See More Articles...